Latest news with #BSGM
Yahoo
28-07-2025
- Business
- Yahoo
Here's 1 New Billion-Dollar Reason to Buy Solana And Never Look Back
Key Points Asset managers are migrating commodities like gold bullion to blockchains. One such business just decided to move its gold holdings onto Solana. These assets are just the early movers in a mega-trend that will benefit the chain. 10 stocks we like better than Solana › Gold has always gravitated toward the world's deepest vaults, starting first with royal treasuries, then central banks, and now, apparently, blockchains. The latest flow is led by BioSig Technologies (NASDAQ: BSGM), which just said it would convert as much as $1.1 billion in physical gold bullion into crypto tokens on the Solana (CRYPTO: SOL) blockchain. For long-term investors, that single decision is one of the clearest signs yet that high-value, highly regulated commodities can, and will, live on Solana. If you have been waiting for a concrete, billion-dollar catalyst before adding to your Solana stack, this might be it. Here's why. This chain is getting gilded On July 7, BioSig inked a financing deal worth as much as $1.1 billion to build a commodities tokenization platform, starting with gold. A bit later, it was confirmed that the company would issue those gold-backed tokens on Solana's chain. That single project is enormous relative to Solana's current real-world asset (RWA) footprint; all tokenized real-world assets on Solana total about $536 million today. If the full $1.1 billion in gold bullion shows up on-chain, the value of RWAs hosted by the network could thus jump by roughly threefold overnight. And that would certainly have a very positive impact on the coin's price. But why did this business choose Solana specifically? In short, it was the chain's low fees, which are typically fractions of a cent, and its lightning-fast transaction processing times, both of which matter when every token represents a bar of gold worth tens of thousands of dollars. The chain's average throughput is about 1,671 transactions per second (TPS) as of noon on July 24, with its development roadmap aiming much higher via the upcoming Firedancer upgrade. Those performance stats will help treasurers move bullion-backed tokens (or any other kind of token) quickly without worrying about network congestion or fee spikes. In other words, BioSig's bullion is finding a new home, and in doing so it is endorsing Solana's technical design as fit for purpose in the ultra-conservative world of precious metals custody. That kind of validation is hard to buy, and even harder to ignore. The tokenization segment is the future Real-world-asset tokenization is no niche experiment, and it's likely going to be a huge driver of growth for Solana, as well as perhaps a few of its competitors. Boston Consulting Group (BCG) projects that just over $16 trillion of illiquid assets could be tokenized on-chain by 2030. Today, just $25 billion is tokenized across all chains, leaving a colossal runway for expansion. Importantly, the ultimate winners of the tokenization trend are not decided yet, though there are a handful of early leaders, of which Solana is one. The chain is currently experiencing the fastest growth of tokenized stocks in the entire crypto sector, though it only hosts just over $96 million in that category today. Add BioSig's gold tokens to the mix, and Solana suddenly hosts a diversified, multibillion-dollar basket of tokenized U.S. Treasury bills, cash, and commodities. Network fundamentals are already moving in tandem with inflows of new assets, as the chain generated $271 million in network revenue in the second quarter of 2025, topping every other chain for the third straight period. Furthermore, rising revenue signals growing demand for block space, which is almost always a precursor to sustained token appreciation. Of course, nothing travels in a straight line. Other blockchains are vying for the same tokenization pie, and regulators still have to hammer out commodity-token rules in major markets. Yet Solana's design, coupled with a thriving ecosystem of compliance-ready service providers, means it can integrate know-your-customer (KYC) layers without rewriting its core code, which is a valuable capability, especially compared to some of the other players in the sector. Assuming regulators approve genuine commodity tokens at some point -- and early signals look promising -- Solana's head start could solidify into an actual economic moat. But don't bet on that outcome just yet because there are still a lot of issues to resolve. For investors, the takeaway is clear. Each fresh billion of real-world assets onboarded to Solana reinforces part of the investment thesis for the coin, namely that the chain that settles those RWAs fastest and cheapest will gain in value. This is a good time to be buying this coin. Lastly, recognize that BioSig's gold is likely the opening salvo in a wider commodities rush, not an isolated event. So stay tuned. Should you buy stock in Solana right now? Before you buy stock in Solana, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Solana wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Alex Carchidi has positions in Solana. The Motley Fool has positions in and recommends Solana. The Motley Fool has a disclosure policy. Here's 1 New Billion-Dollar Reason to Buy Solana And Never Look Back was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
17-07-2025
- Business
- Business Insider
Streamex (BSGM) CEO Henry McPhie Highlights BSGM Merger and RWA Tokenization Strategy in Live TV Interview
New York, USA, July 17th, 2025, Chainwire In a live financial television interview, Streamex CEO Henry McPhie unveiled new details surrounding the company's strategic merger with BioSig Technologies (NASDAQ: BSGM), which officially positions Streamex as one of the first publicly traded real-world asset (RWA) tokenization companies focused on the $142 trillion commodities market. The interview aired just days after the highly anticipated Circle IPO, which McPhie noted has signaled a 'very bullish market for crypto-related stocks.' 'We were lucky to get to the market even before the Circle IPO,' said McPhie. 'With our merger with BSGM, we've brought Streamex to the Nasdaq, allowing us to deliver a truly innovative public vehicle for commodities tokenization.' The newly merged entity aims to bring real-world commodities on-chain through financial products tailored specifically to the unique dynamics of the sector. According to McPhie, the company's mission centers on the democratization of capital and efficiency of assets — two core principles enabled by blockchain tokenization. 'With tokenization, we can create financial instruments that don't exist today in the commodity space,' he added. 'It's about unlocking value, liquidity, and access.' Backing this mission are key industry veterans now serving as advisors, including: Shaun Rosen, founder of what was once North America's largest mining operation (Osoco Mining) Frank Giustra, a serial entrepreneur who has built multiple companies exceeding $50 billion in combined valuation Streamex is fully regulated in Canada and is actively pursuing U.S. broker-dealer registration to further solidify its presence in North America's financial markets. 'As a first mover in this space, we're paving the path for commodity tokenization to go mainstream — bringing novel, efficient assets to public investors,' said McPhie. Streamex is building the future of real-world asset (RWA) tokenization, with a focus on commodities and hard assets. The company's mission is to create financial instruments that bring efficiency, liquidity, and broader access to global markets through blockchain-based innovation. Contact Michael Pell
Yahoo
08-07-2025
- Business
- Yahoo
BioSig, Streamex to Raise $1.1B for Gold Tokenization Initiative on Solana
BioSig Technologies (BSGM), a medical-technology company fresh off a merger with tokenization firm Streamex, said it signed definitive agreements for up to $1.1 billion in financing to fund a gold-backed treasury model and scale its tokenization platform for real-world assets (RWAs) like gold and other commodities. The capital raise includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit. The debentures accrue 4% interest and are convertible into common shares, giving holders the rights to a sizable equity position. Under the equity line of credit, the firm may issue new shares and sell up to $1 billion of common stock to investors for up 36 months. BSGM shares plunged as much as 43% to $6.54 on Tuesday following the announcement, perhaps on concerns about potential shareholder dilution. The price stabilized later around $9, down 20% during the day. The company's market capitalization is about $1 billion at current prices, according to Yahoo Finance data. Still, it is up roughly 600% since the two firms announced their merger on May 5. A slew of companies have recently said they are pivoting to a crypto treasury strategy, raising capital by selling shares and issuing debt and investing in tokens like bitcoin (BTC) and Ethereum's ether (ETH). BioSig is taking a different approach. The merged entity is positioning itself as a gold treasury company while betting on the red-hot tokenization trend. Tokenized assets, or traditional instruments like stocks, funds and commodities on blockchain rails, are projected to become a multitrillion dollar market over the next years, reports by BCG, McKinsey and Standard Chartered said. The company plans to hold physical gold through a top-tier bullion bank and denominate much of its balance sheet in the yellow metal rather than fiat currency. Meanwhile, Streamex plans to issue tokens backed by gold and other commodities through its platform built on the Solana (SOL) blockchain. "By combining the value of physical gold with the innovation of blockchain, we are building a company grounded in what we believe to be the world's most trusted store of value while enabling a scalable, high-return business model through tokenization," BioSig CEO and Streamex co-founder Henry McPhie said in a statement. "Our mission is to unlock liquidity, transparency, and accessibility across the $142 trillion commodities market, and this milestone is just the beginning," he in to access your portfolio
Yahoo
26-05-2025
- Business
- Yahoo
BioSig Stock Surges Following Share Exchange Deal With Streamex
BioSig Technologies, Inc. BSGM recently entered into a definitive share exchange agreement with Streamex Exchange Corporation (Streamex), a private company focused on the tokenization of real-world assets. This strategic move marks BioSig's entry into the rapidly growing blockchain and digital asset sector, with an emphasis on bringing commodity markets on-chain. With this agreement, BioSig is positioning itself to tap into the growing global commodities market through innovative blockchain solutions. This merger not only diversifies BioSig's business model but also aligns it with the future of decentralized finance, unlocking new opportunities for growth and market relevance in the digital age. Following the announcement, shares of the company soared 24.4% and closed at $5.28 on Friday. In the year-to-date period, BSGM's shares have gained 254.4% against the industry's 10.5% decline. The S&P 500 decreased 1.9% in the same time frame. This deal can significantly boost BSGM's business in the long run by transforming its core identity from a traditional medtech company into a diversified player in the blockchain and digital asset space. By integrating Streamex's platform for real-world asset tokenization, especially in commodities, BSGM gains access to a high-growth, trillion-dollar market far beyond its original scope. This diversification can open new revenue streams, attract fintech-focused investors, and enhance the company's strategic value. Meanwhile, BSGM currently has a market capitalization of $144.1 million. The company expects its earnings to improve 73.3% in 2025 year over year. Image Source: Zacks Investment Research Real-world asset tokenization is the process of converting physical or traditional assets, such as real estate, commodities, or artwork, into digital tokens on a blockchain. These tokens represent ownership or rights to the underlying asset, enabling easier transfer, fractional ownership, and increased liquidity. BSGM is likely to benefit from this deal by gaining access to Streamex's innovative blockchain technology and expertise in real-world asset tokenization, allowing it to diversify beyond medical technology into the fast-growing digital asset and commodities markets. Under the terms of the agreement, Streamex will become a wholly owned subsidiary of BioSig through a share exchange transaction. All outstanding shares of Streamex will be exchanged for new shares of BioSig common stock. Streamex shareholders will receive 75% of BioSig's fully diluted common stock in exchange for all Streamex shares. At closing, they will get 19.9% initially (per Nasdaq rules), and the remaining shares, up to 75%, will be issued after BioSig shareholders approve the deal. Post-approval, existing BioSig shareholders will retain 25% ownership in the combined company. Per a report by MarketsandMarkets, the global tokenization market size was valued at $2.3 billion in 2021, and it is projected to reach $5.6 billion by the end of 2026 at a CAGR of 19.0% during the forecast period. The tokenization market is driven by the growing demand for increased liquidity, transparency, and accessibility in traditional asset markets. Advances in blockchain technology enable the digitization of real-world assets, making it easier to trade, fractionalize, and transfer ownership globally. BSGM carries a Zacks Rank #2 (Buy) at present. Some other top-ranked stocks in the broader medical space that have announced quarterly results are CVS Health Corporation CVS, Integer Holdings Corporation ITGR and AngioDynamics ANGO. CVS Health, carrying a Zacks Rank of 2, reported first-quarter 2025 adjusted earnings per share (EPS) of $2.25, beating the Zacks Consensus Estimate by 31.6%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Revenues of $94.59 billion outpaced the consensus mark by 1.8%. CVS Health has a long-term estimated growth rate of 11.4%. Its earnings surpassed estimates in each of the trailing four quarters, with an average surprise of 18.1%. Integer Holdings reported first-quarter 2025 adjusted EPS of $1.31, beating the Zacks Consensus Estimate by 3.2%. Revenues of $437.4 million surpassed the Zacks Consensus Estimate by 1.3%. It currently sports a Zacks Rank of 1. Integer Holdings has a long-term estimated growth rate of 18.4%. ITGR's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 2.8%. AngioDynamics, currently sporting a Zacks Rank #1, reported a third-quarter fiscal 2025 adjusted EPS of 3 cents against the Zacks Consensus Estimate of a 13-cent loss. Revenues of $72 million beat the Zacks Consensus Estimate by 2%. ANGO has an estimated fiscal 2026 earnings growth rate of 27.8% compared with the S&P 500 Composite's 10.5% growth. AngioDynamics' earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 70.9%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AngioDynamics, Inc. (ANGO) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report Integer Holdings Corporation (ITGR) : Free Stock Analysis Report Biosig Technologies, Inc. (BSGM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
25-05-2025
- Business
- Yahoo
BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition
BioSig Technologies, Inc. (NASDAQ:BSGM) has entered a definitive share exchange agreement with Streamex Exchange Corp, which initiates a bold shift from medical technology to blockchain-powered real-world asset (RWA) tokenization. As per the agreement, Streamex will become a wholly owned subsidiary with its shareholders expected to hold 75% of BioSig's fully diluted common stock, pending shareholder approval. A cardiac surgeon demonstrating a simulated ablation procedure with a signal processing platform. In the combined entity, Streamex's co-founder, Henry McPhie, will step in as CEO, and Morgan Lekstrom will take on the role of Chairman. Current BioSig Technologies, Inc. (NASDAQ:BSGM) CEO Anthony Amato will transition to a board role, signaling the company's retreat from its original medical tech identity. Complying with regulations, the company has initially issued 19.9% of shares to Streamex investors and awaits full approval. The transaction has attracted strategic advisors with high profiles, including Frank Giustra, the founder of Wheaton Precious Metals and GoldCorp, indicating the noteworthiness of the company's entry into the $142.85 trillion global commodity sector. Leveraging its vertically integrated infrastructure, Streamex can gain a competitive edge with tokenization poised to address inefficiencies in commodity trading and settlement. On the other hand, BioSig Technologies, Inc. (NASDAQ:BSGM)'s radical shift introduces considerable uncertainty. Existing shareholder equity is diluted, and the company is also exposed to the operational risks inherent in shifting industries. Additionally, the technical specifications regarding Streamex's blockchain framework have also not been disclosed yet. Notably, while the institutional transaction in BioSig Technologies, Inc. (NASDAQ:BSGM) has increased by 218.41%, the insider transaction remains neutral at 0.00% over the last six months. BSGM could be a potential investment opportunity. But our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSGM and that has 100x upside potential, check out our report about the READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
